Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors, but it has not received MHRA marketing authorisation and cannot be legally prescribed in the UK
Cleveland Clinic: Uterine Fibroids Resilient Sisterhood Project: Black Women and Uterine Fibroids Johns Hopkins Medicine: Fibroids Office on Womens Health: Uterine Fibroids Kara Smythe, MD Medical Reviewer Kara Smythe, MD, has been working in sexual and reproductive health for over 10 years
Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: a randomized controlled trial
This pro-oxidant activity results from Vitamin C's action on metal ions, which generates free radicals and hydrogen peroxide, and is associated with cell toxicity
Handling Bleeding Bleeding will be the most common after-effect, and most of it will happen in the initial two days